These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
332 related articles for article (PubMed ID: 9146664)
1. Vascular endothelial growth factor (VEGF) expression in prostate cancer and benign prostatic hyperplasia. Jackson MW; Bentel JM; Tilley WD J Urol; 1997 Jun; 157(6):2323-8. PubMed ID: 9146664 [TBL] [Abstract][Full Text] [Related]
2. Expression of the VEGF-receptor Flt-1 in benign, premalignant and malignant prostate tissues. Hahn D; Simak R; Steiner GE; Handisurya A; Susani M; Marberger M J Urol; 2000 Aug; 164(2):506-10. PubMed ID: 10893635 [TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor (VEGF) expression in human prostate cancer: in situ and in vitro expression of VEGF by human prostate cancer cells. Ferrer FA; Miller LJ; Andrawis RI; Kurtzman SH; Albertsen PC; Laudone VP; Kreutzer DL J Urol; 1997 Jun; 157(6):2329-33. PubMed ID: 9146665 [TBL] [Abstract][Full Text] [Related]
4. Distribution of vascular endothelial growth factor (VEGF) in prostate disease. Walsh K; Sriprasad S; Hopster D; Codd J; Mulvin D Prostate Cancer Prostatic Dis; 2002; 5(2):119-22. PubMed ID: 12497000 [TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor modulates the expression of vascular endothelial growth factor in the human prostate. Ravindranath N; Wion D; Brachet P; Djakiew D J Androl; 2001; 22(3):432-43. PubMed ID: 11330643 [TBL] [Abstract][Full Text] [Related]
6. Microautoradiographic quantitation of vascular endothelial growth factor mRNA levels in human prostate specimens containing normal and neoplastic epithelium. Woessner RD; Wright PS; Loudy DE; Wallace CD; Montgomery LR; Nestok BR Exp Mol Pathol; 1998; 65(1):37-52. PubMed ID: 9613925 [TBL] [Abstract][Full Text] [Related]
7. Correlation of vascular endothelial growth factor expression with fibroblast growth factor-8 expression and clinico-pathologic parameters in human prostate cancer. West AF; O'Donnell M; Charlton RG; Neal DE; Leung HY Br J Cancer; 2001 Aug; 85(4):576-83. PubMed ID: 11506499 [TBL] [Abstract][Full Text] [Related]
8. Angiogenically active vascular endothelial growth factor is over-expressed in malignant human and rat prostate carcinoma cells. Chen HJ; Treweeke AT; Ke YQ; West DC; Toh CH Br J Cancer; 2000 May; 82(10):1694-701. PubMed ID: 10817506 [TBL] [Abstract][Full Text] [Related]
9. A potential autocrine role for vascular endothelial growth factor in prostate cancer. Jackson MW; Roberts JS; Heckford SE; Ricciardelli C; Stahl J; Choong C; Horsfall DJ; Tilley WD Cancer Res; 2002 Feb; 62(3):854-9. PubMed ID: 11830543 [TBL] [Abstract][Full Text] [Related]
10. Association between immunohistochemical expression of vascular endothelial growth factor (VEGF), VEGF-expressing neuroendocrine-differentiated tumor cells, and outcome in prostate cancer patients subjected to watchful waiting. Borre M; Nerstrøm B; Overgaard J Clin Cancer Res; 2000 May; 6(5):1882-90. PubMed ID: 10815911 [TBL] [Abstract][Full Text] [Related]
11. Expression of vascular endothelial growth factor receptor-3 by lymphatic endothelial cells is associated with lymph node metastasis in prostate cancer. Zeng Y; Opeskin K; Baldwin ME; Horvath LG; Achen MG; Stacker SA; Sutherland RL; Williams ED Clin Cancer Res; 2004 Aug; 10(15):5137-44. PubMed ID: 15297417 [TBL] [Abstract][Full Text] [Related]
12. Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue. Joseph IB; Nelson JB; Denmeade SR; Isaacs JT Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2507-11. PubMed ID: 9815654 [TBL] [Abstract][Full Text] [Related]
13. Expression of vascular endothelial growth factor (VEGF) and VEGF receptor Flk-1 in benign, premalignant, and malignant prostate tissue. Köllermann J; Helpap B Am J Clin Pathol; 2001 Jul; 116(1):115-21. PubMed ID: 11447740 [TBL] [Abstract][Full Text] [Related]
14. Highly metastatic human prostate cancer growing within the prostate of athymic mice overexpresses vascular endothelial growth factor. Balbay MD; Pettaway CA; Kuniyasu H; Inoue K; Ramirez E; Li E; Fidler IJ; Dinney CP Clin Cancer Res; 1999 Apr; 5(4):783-9. PubMed ID: 10213213 [TBL] [Abstract][Full Text] [Related]
15. [Expression of cyclooxygenase-2 and vascular endothelial growth factor in human prostate cancer and its significance]. Jin TX; Li XG; Wu WY; Piao DM; Feng JY; Sang J Zhonghua Nan Ke Xue; 2006 Mar; 12(3):207-10. PubMed ID: 16597032 [TBL] [Abstract][Full Text] [Related]
16. Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: expression of lymphangiogenic markers is associated with advanced-stage disease. Kaushal V; Mukunyadzi P; Dennis RA; Siegel ER; Johnson DE; Kohli M Clin Cancer Res; 2005 Jan; 11(2 Pt 1):584-93. PubMed ID: 15701844 [TBL] [Abstract][Full Text] [Related]
17. [Expression of VEGF in prostate cancer and its correlation with ET-1]. Zhou WQ; Yin HL; Zhang ZY; Yi XM; Ge JP; Zhou SG; Cheng W; Wei W; Ma HQ; Ma HH; Gao JP Zhonghua Nan Ke Xue; 2008 Nov; 14(11):987-92. PubMed ID: 19102498 [TBL] [Abstract][Full Text] [Related]
18. Expression analysis of peptide growth factors VEGF, FGF2, TGFB1, EGF and IGF1 in prostate cancer and benign prostatic hyperplasia. Soulitzis N; Karyotis I; Delakas D; Spandidos DA Int J Oncol; 2006 Aug; 29(2):305-14. PubMed ID: 16820871 [TBL] [Abstract][Full Text] [Related]
19. Expression of vascular endothelial growth factor (VEGF) and its mRNA in uterine cervical cancers. Fujimoto J; Sakaguchi H; Hirose R; Ichigo S; Tamaya T Br J Cancer; 1999 May; 80(5-6):827-33. PubMed ID: 10360662 [TBL] [Abstract][Full Text] [Related]
20. [Expressions of telomerase reverse transcriptase and vascular endothelial growth factor and their correlation in prostate cancer]. Li X; Wang N; Zhang Y; Zhang SX; Lin Q; Tang J Zhonghua Nan Ke Xue; 2005 Oct; 11(10):724-6, 730. PubMed ID: 16281501 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]